Send feedback

PC p.Arg675His

c.2024G>A · rs375528540 · VCV1397136

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.9275 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
pyruvate carboxylase deficiency disease

Computational evidence

Protein change
AlphaMissense0.9275likely pathogenic
REVEL0.897moderately pathogenic-leaning
SaProtLLR -14.93damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 1.4, phastCons 1
Regional constrainto/e 0.74unconstrained · MANE · 23 kb · p 3.1e-25 · regional, not allelic
Overall
CADD29.6PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/74,932 alleles
Filtering AF 0.000247% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000159%
Overall 0.000686% 11/1,604,040 alleles · very rare exomes 9/1,451,810 · genomes 2/152,230 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,606
Finnishnot grpmax-eligible 0.00185% 54,102
Remaining individualsnot grpmax-eligible 0.0016% 62,436
African / African-Americangrpmax 0.00133% 74,932
European (non-Finnish) 0.000593% 168,567

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PC
Protein
p.Arg675His
Coding
c.2024G>A
MANE Select
NM_001040716
dbSNP
rs375528540
Type
single nucleotide variant
Location
chr11:66851239 (GRCh38)
Gene constraint
LOEUF 0.539 · pLI 0.07 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 90.53 · 10 PDB
Residue 675
a β-strand; the pyruvate carboxyltransferase domain
Full PC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

pyruvate carboxylase deficiency disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Pyruvate carboxylase deficiency (Orphanet):

Inheritance
Autosomal recessive, Not applicable
Onset
Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pc-p-arg675his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown